BioSpace News Archive

Precision BioSciences, Inc., a genome editing company dedicated to improving life through the application of its pioneering, proprietary ARCUS® platform, announced that it will publish financial results for the third quarter of 2019 and provide a corporate update on November 12, 2019.

HTL, world leading supplier of Hyaluronic Acid and other biopolymer solutions, announces it is investing in a state-of-the-art production facility that will multiply its injectable grade sodium hyaluronate production capacity by 2.5 by 2021.

Soft Bones, Inc. is proud to award its annual Maher Family Grant to fund HPP studies

Natera, Inc., a global leader in cell-free DNA testing, announced that it will release results for its third quarter ended September 30, 2019, after the market close on November 6, 2019.

Collaboration facilitated by the Bill & Melinda Gates Foundation through an expansion of an existing grant to Mologic

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on defined bacterial consortia, is pleased to announce that its co-founder and CEO Bernat Olle, Ph.D., received the 2019 Barry M. Portnoy Immigrant Entrepreneur Award from The Immigrant Learning Center in the Life Science Business category.

Pear deepens its Prescription Digital Therapeutics (PDTs) pipeline and expands its platform outside of brain-related conditions

Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for potentially life-threatening food allergies, announced that it will host a conference call on Wednesday, November 6, 2019, at 4:30 p.m. ET to discuss its financial results for the quarter ended September 30, 2019, and recent operational highlights.

ArQule, Inc. announced its financial results for the third quarter of 2019.

Bristol-Myers Squibb Company and LabCentral, an innovative, shared laboratory space designed as a launchpad for life sciences and biotech startups, announced that Carmine Therapeutics and STIMIT are the winners of Bristol-Myers Squibb’s 2019 Golden Tickets for LabCentral.